Key facts
- This page summarizes Eric Bjerkholt's Form 4 filing for Mirum Pharmaceuticals, Inc. (MIRM).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 17 Mar 2026, 19:30.
Eric Bjerkholt - 15 Mar 2026 Form 4 Insider Report for Mirum Pharmaceuticals, Inc. (MIRM)
- Reporting relationship
- CHIEF FINANCIAL OFFICER
- Issuer ticker
- MIRM
- Reported as of
- 15 Mar 2026
- Net transaction value
- -$670,243
- SEC form
- 4
- Accepted by SEC
- 17 Mar 2026, 19:30:20 UTC
- Prior SEC filing
- 30 Jan 2026
- Next SEC filing
- 14 May 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Judit Ryvkin, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Eric Bjerkholt filed Form 4 for Mirum Pharmaceuticals, Inc. (MIRM) on 17 Mar 2026.
Change
- Previous filing in this sequence was filed on 30 Jan 2026.
- Current net transaction value: -$670,243.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001197350
Primary reporting owner
BJERKHOLT ERIC
- Relationship
- CHIEF FINANCIAL OFFICER
- Address
- C/O MIRUM PHARMACEUTICALS, INC., 989 E HILLSDALE BLVD., SUITE 300, FOSTER CITY
- Signature
- /s/ Judit Ryvkin, Attorney-in-Fact
- Signature date
- 17 Mar 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MIRM
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +13,334
- Change %
- +30%
- Price
- Shares after
- 57,075
- Date
- 15 Mar 2026
- Ownership
- Direct
- Footnotes
- F1
MIRM
transaction
Common Stock
Sale
- Transaction value
- $670,243
- Shares
- -7,287
- Change %
- -13%
- Price
- $91.98
- Shares after
- 49,788
- Date
- 16 Mar 2026
- Ownership
- Direct
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
MIRM
transaction
Derivative
Performance Restricted Stock Units
Options Exercise
- Transaction value
- Shares
- -13,334
- Change %
- -67%
- Price
- $0.000000*
- Shares after
- 6,666
- Date
- 15 Mar 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 13,334
- Exercise price
- Footnotes
- F1, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Each performance restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
Footnote F2
Shares sold to cover tax withholding obligations associated with the vesting of the performance restricted stock units.
Footnote F3
The shares vest as follows: 2/3 of the shares vest on March 15, 2026 and 1/3 of the shares vest on March 15, 2027.